Lupin launches generic medication in US market

Drug firm Lupin on Tuesday said it has launched a generic anti-psychotic medication in the US market. The company’s product, in strengths of 20 mg, 40 mg, 60 mg, 80 mg and 120 mg, is the generic equivalent of Sunovion Pharmaceuticals Inc’s Latuda tablets.

Banks seek more time to report loan frauds to RBI

“The issue was discussed in a meeting last month. We have suggested to the RBI that instead of one week, the reporting time should be increased to around a month,” said a senior bank executive aware of the development. Under the existing framework, lenders need to report fraud to the RBI’s Central Repository of Information on Large Credits (CRILC) within a week of the joint lenders’ forum (JLF) declaring an account fraudulent.